Playback speed
10 seconds
ASH 2023 Insights: "Efficacy of Ibrutinib Arms Across ALPINE and ELEVATE-RR Trials in R/R CLL - A Matching-Adjusted Indirect Comparison"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Mazyar Shadman
By
Insights from 2023 ASH Annual Meeting
FEATURING
Mazyar Shadman
702 views
December 19, 2023
Login to view comments.
Click here to Login